Stockreport

VarmX Partners With CSL in a Strategic Collaboration and Option Agreement to Develop Novel Investigational Coagulation Treatment

CSL LTD SP/ADR  (CSLLY) 
NASDAQ:AMEX Investor Relations: csl.com/investors
PDF Full funding of VMX-C001 Phase 3 trial, late-stage product development, manufacturing and pre-launch activitiesVarmX shareholders to receive initial $117m upfront and fu [Read more]